562 results on '"Rouby, Jean-Jacques"'
Search Results
2. Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies
- Author
-
Dhanani, Jayesh, Roberts, Jason A., Monsel, Antoine, Torres, Antoni, Kollef, Marin, and Rouby, Jean-Jacques
- Published
- 2024
- Full Text
- View/download PDF
3. Aerosol therapy in adult critically ill patients: a consensus statement regarding aerosol administration strategies during various modes of respiratory support
- Author
-
Li, Jie, Liu, Kai, Lyu, Shan, Jing, Guoqiang, Dai, Bing, Dhand, Rajiv, Lin, Hui-Ling, Pelosi, Paolo, Berlinski, Ariel, Rello, Jordi, Torres, Antoni, Luyt, Charles-Edouard, Michotte, Jean-Bernard, Lu, Qin, Reychler, Gregory, Vecellio, Laurent, de Andrade, Armèle Dornelas, Rouby, Jean-Jacques, Fink, James B., and Ehrmann, Stephan
- Published
- 2023
- Full Text
- View/download PDF
4. Aerosolised antibiotics in critical care
- Author
-
Rello, Jordi, Bouglé, Adrien, and Rouby, Jean-Jacques
- Subjects
Medical colleges ,Antibiotics ,Health care industry - Abstract
Author(s): Jordi Rello [sup.1] [sup.2] [sup.3], Adrien Bouglé [sup.4], Jean-Jacques Rouby [sup.5] Author Affiliations: (1) grid.430994.3, 0000 0004 1763 0287, Global Health eCore, Vall d'Hebron Institute of Research (VHIR), , [...]
- Published
- 2023
- Full Text
- View/download PDF
5. Ultrasound-based clinical profiles for predicting the risk of intradialytic hypotension in critically ill patients on intermittent dialysis: a prospective observational study
- Author
-
da Hora Passos, Rogerio, Caldas, Juliana, Ramos, Joao Gabriel Rosa, dos Santos Galvão de Melo, Erica Batista, Ribeiro, Michel Por Deus, Alves, Maria Fernanda Coelho, Batista, Paulo Benigno Pena, Messeder, Octavio Henrique Coelho, de Carvalho de Farias, Augusto Manoel, Macedo, Etienne, and Rouby, Jean Jacques
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Lung ,Cardiovascular ,Clinical Research ,Kidney Disease ,Good Health and Well Being ,APACHE ,Acute Kidney Injury ,Aged ,Dialysis ,Female ,Humans ,Hypotension ,Male ,Middle Aged ,Organ Dysfunction Scores ,Prospective Studies ,Statistics ,Nonparametric ,Ultrasonography ,Ultrasound ,Acute kidney injury ,Critically ill patients ,Profiles ,Medical and Health Sciences ,Emergency & Critical Care Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundIntradialytic hypotension, a complication of intermittent hemodialysis, decreases the efficacy of dialysis and increases long-term mortality. This study was aimed to determine whether different predialysis ultrasound cardiopulmonary profiles could predict intradialytic hypotension.MethodsThis prospective observational single-center study was performed in 248 critically ill patients with acute kidney injury undergoing intermittent hemodialysis. Immediately before hemodialysis, vena cava collapsibility was measured by vena cava ultrasound and pulmonary congestion by lung ultrasound. Factors predicting intradialytic hypotension were identified by multiple logistic regression analysis.ResultsIntradialytic hypotension was observed in 31.9% (n = 79) of the patients, interruption of dialysis because of intradialytic hypotension occurred in 6.8% (n = 31) of the sessions, and overall 28-day mortality was 20.1% (n = 50). Patients were classified in four ultrasound profiles: (A) 108 with B lines > 14 and vena cava collapsibility > 11.5 mm m-2, (B) 38 with B lines 14 and vena cava collapsibility Di ≤ 11.5 mm m-2, and (D) 66 with B lines 11.5 mm m-2. There was an increased risk of intradialytic hypotension in patients receiving norepinephrine (odds ratios = 15, p = 0.001) and with profiles B (odds ratios = 12, p = 0.001) and C (odds ratios = 17, p = 0.001).ConclusionIn critically ill patients on intermittent hemodialysis, the absence of hypervolemia as assessed by lung and vena cava ultrasound predisposes to intradialytic hypotension and suggests alternative techniques of hemodialysis to provide better hemodynamic stability.
- Published
- 2019
6. Usefulness of lung ultrasound for early detection of hospital-acquired pneumonia in cardiac critically ill patients on venoarterial extracorporeal membrane oxygenation
- Author
-
Pasqueron, Jean, Dureau, Pauline, Arcile, Gauthier, Duceau, Baptiste, Hariri, Geoffroy, Lepère, Victoria, Lebreton, Guillaume, Rouby, Jean-Jacques, and Bouglé, Adrien
- Published
- 2022
- Full Text
- View/download PDF
7. Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
- Author
-
Rouby, Jean-Jacques, Zhu, Yinggang, Torres, Antoni, Rello, Jordi, and Monsel, Antoine
- Published
- 2022
- Full Text
- View/download PDF
8. Intraoperative pulmonary hyperdistention estimated by transthoracic lung ultrasound: A pilot study
- Author
-
Tonelotto, Bruno, Pereira, Sérgio Martins, Tucci, Mauro Roberto, Vaz, Diogo Florenzano, Vieira, Joaquim Edson, Malbouisson, Luiz Marcelo, Gay, Frédérick, Simões, Claudia Marquez, Carvalho Carmona, Maria José, Monsel, Antoine, Amato, Marcelo Brito, Rouby, Jean-Jacques, and Costa Auler, José Otavio, Jr.
- Published
- 2020
- Full Text
- View/download PDF
9. Functional respiratory imaging of the airways in the acute respiratory distress syndrome
- Author
-
Schepens, Tom, Lu, Xiao, Van Holsbeke, Cedric, Vos, Wim, De Backer, Jan, Parizel, Paul M., De Backer, Wilfried, Lu, Qin, Rouby, Jean-Jacques, and Jorens, Philippe G.
- Published
- 2020
- Full Text
- View/download PDF
10. T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: A prospective single-centre observational study
- Author
-
Halter, Sebastien, Aimade, Lucrèce, Barbié, Michèle, Brisson, Hélène, Rouby, Jean-Jacques, Langeron, Olivier, Klatzmann, David, Rosenzwajg, Michelle, and Monsel, Antoine
- Published
- 2020
- Full Text
- View/download PDF
11. SARS-CoV-2 pneumonia—receptor binding and lung immunopathology: a narrative review
- Author
-
Menezes, Maria Clara Saad, Pestana, Diego Vinicius Santinelli, Gameiro, Gustavo Rosa, da Silva, Luiz Fernando Ferraz, Baron, Ėlodie, Rouby, Jean-Jacques, and Auler Jr, José Otavio Costa
- Published
- 2021
- Full Text
- View/download PDF
12. Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice
- Author
-
Monsel, Antoine, Zhu, Ying-gang, Gennai, Stephane, Hao, Qi, Hu, Shuling, Rouby, Jean-Jacques, Rosenzwajg, Michelle, Matthay, Michael A, and Lee, Jae W
- Subjects
Infectious Diseases ,Lung ,Stem Cell Research ,Pneumonia ,Pneumonia & Influenza ,Stem Cell Research - Nonembryonic - Human ,Regenerative Medicine ,2.1 Biological and endogenous factors ,Aetiology ,Respiratory ,Acute Lung Injury ,Animals ,Cell-Derived Microparticles ,Cells ,Cultured ,Disease Models ,Animal ,Humans ,Male ,Mesenchymal Stem Cell Transplantation ,Mesenchymal Stem Cells ,Mice ,Mice ,Inbred C57BL ,Pneumonia ,Bacterial ,acute respiratory distress syndrome ,bacterial pneumonia ,mesenchymal stem cells ,microvesicles ,Medical and Health Sciences ,Respiratory System - Abstract
RationaleMicrovesicles (MVs) are anuclear fragments of cells released from the endosomal compartment or shed from surface membranes. We and other investigators demonstrated that MVs released by mesenchymal stem cells (MSCs) were as effective as the cells themselves in inflammatory injuries, such as after endotoxin-induced acute lung injury. However, the therapeutic effects of MVs in an infectious model of acute lung injury remain unknown.ObjectivesWe investigated the effects of human MSC MVs on lung inflammation, protein permeability, bacterial clearance, and survival after severe bacterial pneumonia.MethodsWe tested the effects of MVs derived from human MSCs on Escherichia coli pneumonia in mice. We also studied the interactions between MVs and human monocytes and human alveolar epithelial type 2 cells.Measurements and main resultsAdministration of MVs derived from human MSCs improved survival in part through keratinocyte growth factor secretion and decreased the influx of inflammatory cells, cytokines, protein, and bacteria in mice injured with bacterial pneumonia. In primary cultures of human monocytes or alveolar type 2 cells, the uptake of MVs was mediated by CD44 receptors, which were essential for the therapeutic effects. MVs enhanced monocyte phagocytosis of bacteria while decreasing inflammatory cytokine secretion and increased intracellular ATP levels in injured alveolar epithelial type 2 cells. Prestimulation of MSCs with a toll-like receptor 3 agonist further enhanced the therapeutic effects of the released MVs.ConclusionsMVs derived from human MSCs were as effective as the parent stem cells in severe bacterial pneumonia.
- Published
- 2015
13. Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial
- Author
-
Sophie, Cayot, Thomas, Godet, Renaud, Guerin, Camille, Verlac, Russel, Chabanne, Bernard, Cosserant, Raiko, Blondonnet, Alexandre, Lautrette, Nathanael, Eisenmann, Laurent, Muller, Pablo, Massanet, Caroline, Boutin, Saber, Barbar, Claire, Roger, Fouad, Belafia, Moussa, Cisse, Marion, Monnin, Matthieu, Conseil, Julie, Carr, Audrey, De Jong, Auguste, Dargent, Pascal, Andreu, Thomas, Lebouvrier, Yoann, Launey, Antoine, Roquilly, Raphael, Cinotti, Anne-Charlotte, Tellier, Mathilde, Barbaz, Benjamin, Cohen, Edouard, Lemarche, Pierre-Marie, Bertrand, Charlotte, Arberlot, Laurent, Zieleskiewicz, Emmanuelle, Hammad, Garry, Duclos, Calypso, Mathie, Herve, Dupont, Benoit, Veber, Jean-Christophe, Orban, Hervé, Quintard, Thomas, Rimmele, Julien, Crozon-Clauzel, Marinne, Le Core, Fabien, Grelon, Mona, Assefi, Frank, Petitas, Jerome, Morel, Serge, Molliex, Nanadougmar, Hadanou, Constantin, Jean-Michel, Jabaudon, Matthieu, Lefrant, Jean-Yves, Jaber, Samir, Quenot, Jean-Pierre, Langeron, Olivier, Ferrandière, Martine, Grelon, Fabien, Seguin, Philippe, Ichai, Carole, Veber, Benoit, Souweine, Bertrand, Uberti, Thomas, Lasocki, Sigismond, Legay, François, Leone, Marc, Eisenmann, Nathanael, Dahyot-Fizelier, Claire, Dupont, Hervé, Asehnoune, Karim, Sossou, Achille, Chanques, Gérald, Muller, Laurent, Bazin, Jean-Etienne, Monsel, Antoine, Borao, Lucile, Garcier, Jean-Marc, Rouby, Jean-Jacques, Pereira, Bruno, and Futier, Emmanuel
- Published
- 2019
- Full Text
- View/download PDF
14. Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study
- Author
-
Constantin, Jean-Michel, Chastre, Jean, Amour, Julien, Vezinet, Corine, Rouby, Jean-Jacques, Raux, Mathieu, Langeron, Olivier, Degos, Vincent, Bolgert, Francis, Weiss, Nicolas, Similowski, Thomas, Demoule, Alexandre, Duguet, Alexandre, Tollard, Eleonore, Veber, Benoit, Lotterie, Jean-Albert, SANCHEZ-PENA, Paola, Génestal, Michèle, Patassini, Mirko, Velly, Lionel, Perlbarg, Vincent, Boulier, Thomas, Adam, Nicolas, Delphine, Sebastien, Luyt, Charles-Edouard, Battisti, Valentine, Torkomian, Gregory, Arbelot, Charlotte, Chabanne, Russell, Jean, Betty, Di Perri, Carol, Laureys, Steven, Citerio, Giuseppe, Vargiolu, Alessia, Rohaut, Benjamin, Bruder, Nicolas, Girard, Nadine, Silva, Stein, Cottenceau, Vincent, Tourdias, Thomas, Coulon, Olivier, Riou, Bruno, Naccache, Lionel, Gupta, Rajiv, Benali, Habib, Galanaud, Damien, and Puybasset, Louis
- Published
- 2018
- Full Text
- View/download PDF
15. Lung Ultrasound in Emergency and Critically Ill Patients: Number of Supervised Exams to Reach Basic Competence
- Author
-
Arbelot, Charlotte, Dexheimer Neto, Felippe Leopoldo, Gao, Yuzhi, Brisson, Hélène, Chunyao, Wang, Lv, Jie, Valente Barbas, Carmen Silvia, Perbet, Sébastien, Prior Caltabellotta, Fabiola, Gay, Frédérick, Deransy, Romain, Lima, Emidio J. S., Cebey, Andres, Monsel, Antoine, Neves, Julio, Zhang, Mao, Bin, Du, An, Youzhong, Malbouisson, Luis, Salluh, Jorge, Constantin, Jean-Michel, Rouby, Jean-Jacques, Biestro, Alberto, Vezinet, Corinne, Garçon, Pierre, El Hadj Kacem, Nabil, Lemesle, Denis, Lucena, Bruno, de Paula Pinto Schettino, Guilherme, Cristovao, Davi, de Tarso Roth Dalcin, Paulo, and Carmona, Maria José Carvalho
- Published
- 2020
- Full Text
- View/download PDF
16. Lung Ultrasound Training in the Critically Ill: Reply
- Author
-
Rouby, Jean-Jacques, Dexheimer Neto, Felippe Leopoldo, Zhang, Mao, Sà Malbouisson, Luiz Marcello, Lv, Jie, and Arbelot, Charlotte
- Published
- 2020
- Full Text
- View/download PDF
17. Nebulization of Vancomycin Provides Higher Lung Tissue Concentrations than Intravenous Administration in Ventilated Female Piglets with Healthy Lungs
- Author
-
Morais, Cristiane Luchesi de Mello, Nascimento, Jorge Willian Leandro, Ribeiro, Aline Corrêa, Cortinez, Luis Ignacio, Carmona, Maria José Carvalho, Maia, Débora Rothstein Ramos, Monsel, Antoine, Auler, José Otavio Costa, Jr., Rouby, Jean-Jacques, and Otsuki, Denise Aya
- Published
- 2020
- Full Text
- View/download PDF
18. Colour Doppler ultrasound after major cardiac surgery improves diagnostic accuracy of the pulmonary infection score in acute respiratory failure: A prospective observational study
- Author
-
Dureau, Pauline, Bouglé, Adrien, Melac, Audrey Tanguy, Ait Hamou, Nora, Arbelot, Charlotte, Ben Hassen, Kais, Charfeddine, Ahmed, Deransy, Romain, Arcile, Gauthier, Rouby, Jean-Jacques, Granger, Benjamin, and Amour, Julien
- Published
- 2019
- Full Text
- View/download PDF
19. Elevated Plasma Levels of sRAGE Are Associated With Nonfocal CT-Based Lung Imaging in Patients With ARDS: A Prospective Multicenter Study
- Author
-
Mrozek, Segolene, Jabaudon, Matthieu, Jaber, Samir, Paugam-Burtz, Catherine, Lefrant, Jean-Yves, Rouby, Jean-Jacques, Asehnoune, Karim, Allaouchiche, Bernard, Baldesi, Olivier, Leone, Marc, Lu, Qin, Bazin, Jean-Etienne, Roszyk, Laurence, Sapin, Vincent, Futier, Emmanuel, Pereira, Bruno, and Constantin, Jean-Michel
- Published
- 2016
- Full Text
- View/download PDF
20. Nebulized Antibiotics: Epithelial Lining Fluid Concentrations Overestimate Lung Tissue Concentrations
- Author
-
Rouby, Jean-Jacques and Monsel, Antoine
- Published
- 2019
- Full Text
- View/download PDF
21. Trendelenburg Position and Morbid Obesity: A Respiratory Challenge for the Anesthesiologist
- Author
-
Rouby, Jean-Jacques, Monsel, Antoine, Lucidarme, Olivier, and Constantin, Jean-Michel
- Published
- 2019
- Full Text
- View/download PDF
22. Management of severe trauma worldwide: implementation of trauma systems in emerging countries: China, Russia and South Africa
- Author
-
Zhou, Jing, Wang, Tianbing, Belenkiy, Igor, Hardcastle, Timothy Craig, Rouby, Jean-Jacques, Jiang, Baoguo, Demetriades, Demetrios, Oestern, Hans, Iwase, Hiroaki, Zhang, Mao, Bouzat, Pierre, Coats, Timothy, Gauss, Tobias, An, Youzhong, Hardcastle, Timothy, Service d'Anesthésie réanimation [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
- Subjects
China ,Review ,Certification ,030230 surgery ,Critical Care and Intensive Care Medicine ,Global Burden of Disease ,Russia ,South Africa ,03 medical and health sciences ,0302 clinical medicine ,Chinese trauma system ,Multidisciplinary approach ,medicine ,Humans ,Registries ,[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,Emerging markets ,In-hospital care ,Accreditation ,Russian trauma system ,business.industry ,RC86-88.9 ,Trauma center ,Trauma registry ,030208 emergency & critical care medicine ,Trauma system ,Trauma care ,Medical emergencies. Critical care. Intensive care. First aid ,Private sector ,medicine.disease ,3. Good health ,Advanced life support ,South African trauma system ,Wounds and Injuries ,Medical emergency ,business ,Delivery of Health Care ,Pre-hospital care - Abstract
As emerging countries, China, Russia, and South Africa are establishing and/or improving their trauma systems. China has recently established a trauma system named “the Chinese Regional Trauma Care System” and covered over 200 million populations. It includes paramedic-staffed pre-hospital care, in-hospital care in certified trauma centers, trauma registry, quality assurance, continuous improvement and ongoing coverage of the entire Chinese territory. The Russian trauma system was formed in the first decade of the twenty-first century. Pre-hospital care is region-based, with a regional coordination center that determines which team will go to the scene and the nearest hospital where the victim should be transported. Physician-staffed ambulances are organized according to three levels of trauma severity corresponding to three levels of trauma centers where in-hospital care is managed by a trauma team. No national trauma registry exists in Russia. Improvements to the Russian trauma system have been scheduled. There is no unified trauma system in South Africa, and trauma care is organized by public and private emergency medical service in each province. During the pre-hospital care, paramedics provide basic or advanced life support services and transport the patients to the nearest hospital because of the limited number of trauma centers. In-hospital care is inclusive with a limited number of accredited trauma centers. In-hospital care is managed by emergency medicine with multidisciplinary care by the various specialties. There is no national trauma registry in South Africa. The South African trauma system is facing multiple challenges. An increase in financial support, training for primary emergency trauma care, and coordination of private sector, need to be planned. Supplementary Information The online version contains supplementary material available at 10.1186/s13054-021-03681-8.
- Published
- 2021
23. Ischaemic colitis: Indications, extent, and results of standardized emergency surgery
- Author
-
Moszkowicz, David, Trésallet, Christophe, Mariani, Antoine, Lefevre, Jérémie H., Godiris-Petit, Gaëlle, Noullet, Séverine, Rouby, Jean-Jacques, and Menegaux, Fabrice
- Published
- 2014
- Full Text
- View/download PDF
24. Sevoflurane in Acute Respiratory Distress Syndrome: Are Lung Protection and Anesthesia Depth Influenced by Pulmonary Morphology?
- Author
-
Riché, Anne, Adam, Nicolas, Monsel, Antoine, Xia, Jing, Langeron, Olivier, and Rouby, Jean-Jacques
- Published
- 2018
- Full Text
- View/download PDF
25. Modification of Tracheal Cuff Shape and Continuous Cuff Pressure Control to Prevent Microaspiration in an Ex Vivo Pig Tracheal Two-Lung Model
- Author
-
Monsel, Antoine, Le Corre, Marine, Deransy, Romain, Brisson, Hélène, Arbelot, Charlotte, Lu, Qin, Golmard, Jean-Louis, Langeron, Olivier, and Rouby, Jean-Jacques
- Published
- 2017
- Full Text
- View/download PDF
26. Significado do ponto de inflexão inferior da curva pressão-volume em pacientes com insuficiência respiratória aguda: avaliação por tomografia computadorizada
- Author
-
R.R. Vieira, Silvia, Puybasset, Louis, Lu, Qin, Richecoeur, Jack, Cluzel, Philippe, Coriat, Pierre x, and Rouby, Jean-Jacques
- Subjects
síndrome da angústia respiratória aguda ,pressão expiratória final positiva ,Acute lung injury ,lower inflection point ,computed tomography ,ponto de inflexão inferior ,tomografia computadorizada ,acute respiratory distress syndrome ,Lesão pulmonar aguda ,positive end-expiratory pressure - Abstract
OBJECTIVE: The goal of this study was to assess lung morphology in patients with acute lung injury according to the presence or the absence of a lower inflection point on the lung pressure-volume curve and to compare the effects of positive endexpiratory pressure (PEEP).MATERIALS AND METHODS: Eight patients with and six without a lower inflection point (LIP) underwent a computed tomography performed at zero end-expiratory pressure (ZEEP) and at two levels of PEEP: PEEP1 = LIP + 2 cmH2O e PEEP2 = LIP + 7 cmH2O, or PEEP1 = 10 cmH2O and PEEP2 = 15 cmH2O in the absence of LIP and, based on the analysis of the lung density histograms, the gas-tissue ratio and the lung areas volumes were calculated (nonaerated, poorly aerated, normally aerated and overdistended volumes).RESULTS: In the ZEEP condition, patients with and without LIP presented similar total lung volume, volume of gas, and volume of tissue, although the percentage ofnormally aerated lung was lower and the percentage of poorly aerated lung was greater in patients with LIP than in patients without it. Lung density histograms ofpatients with LIP showed an unimodal distribution with a peak at 7 Housenfield units (HU), while histograms of patients without LIP had a bimodal distribution, with a first peak at -727 HU, and a second at 27 HU. Lung compliances were lower in patients with LIP whereas all other cardiorespiratory parameters were similar in the two groups. In both groups, PEEP induced an alveolar recruitment that was associated with lung overdistension only in patients without LIP.CONCLUSIONS: The evaluation of the pressure-volume curve in patients with acute lung injury allows us to divide them into two groups according to the presence or absence of LIP. This division is associated with the differences in lung morphology and in the responses to PEEP application in terms of alveolar recruitment andoverdistention, the latter being defined as the occurrence of pulmonary parenchyma under -900 HU. In patients with LIP, gas and tissue are more homogeneously distributed within the lungs and increasing levels of PEEP result in additional alveolarrecruitment without lung overdistention. In patients without LIP, normally aerated areas coexist with nonareted lung areas and increasing levels of PEEP result in lung overdistention rather than in additional alveolar recruitment. OBJETIVO: O objetivo deste estudo foi avaliar, através de tomografia computadorizada, a morfologia pulmonar em pacientes com lesão pulmonar aguda de acordo com a presença ou ausência de ponto de inflexão inferior (Pinf) nas curvas pressão-volume e comparar os efeitos da pressão expiratória final positiva (PEEP).MATERIAIS E MÉTODOS: Oito pacientes com e seis sem Pinf foram submetidos a tomografias computadorizadas realizadas em zero de pressão expiratória final positiva(ZEEP) e em dois níveis de PEEP: PEEP1 = Pinf+2 cmH2O e PEEP2 = Pinf+7 cmH2O, ou PEEP1 = 10 cmH2O e PEEP2 = 15 cmH2O na ausência de Pinf e, a partir da análise dos histogramas de densidade pulmonares, foram calculados a razão gás-tecido e os volumes pulmonares regionais (volumes não-aerado, pobremente aerado, normalmente aerado e hiperdistendido).RESULTADOS: Os pacientes com e sem Pinf apresentaram, em ZEEP, valores similares de volume pulmonar total e volume de gás e tecido, mas a porcentagem de pulmão normalmente ventilado foi menor e a de pulmão pobremente ventilado maior em pacientes com Pinf do que em pacientes sem Pinf. Os histogramas de densidade pulmonares de pacientes com Pinf mostraram uma distribuição unimodal com um pico em 7 unidades Hounsfield (UH), enquanto os pacientes sem Pinf tinham uma distribuição bimodal com um primeiro pico em -727 UH e um segundo em 27 UH. A complacência do sistema respiratório era menor em pacientes com Pinf, enquanto todos os outros parâmetros cardiorrespiratórios eram similares nosdois grupos. Em ambos os grupos, PEEP induziu recrutamento alveolar, o qual foi associado à hiperdistensão pulmonar apenas nos pacientes sem Pinf.CONCLUSÕES: A avaliação das curvas pressão-volume em portadores de lesão pulmonar aguda permite dividi-los em dois grupos, de acordo com a presença ouausência de ponto de inflexão inferior. Esta divisão associa-se com diferenças na morfologia pulmonar e nas respostas à aplicação de PEEP em termos de recrutamento alveolar e hiperdistensão, definindo-se esta última como a ocorrência de parênquima pulmonar abaixo de -900 UH. Em pacientes com Pinf, gás e tecido estão mais homogeneamente distribuídos no interior dos pulmões, e níveis crescentes de PEEP resultam em recrutamento alveolar adicional sem hiperdistensão. Em pacientes sem Pinf, regiões pulmonares normalmente ventiladas coexistem com regiões não-ventiladas, e a aplicação de PEEP, embora cause recrutamento, acarretatambém hiperdistensão, que aumenta com níveis crescentes de PEEP.
- Published
- 2022
27. Comparação de três métodos para medida das curvas de complacência em pacientes com insuficiência respiratória aguda
- Author
-
Lu, Qin, R.R. Vieira, Silvia, Richecoeur, Jack, Puybasset, Louis, Kalfon, Pierre, Coriat, Pierre, and Rouby, Jean-Jacques
- Subjects
síndrome da angústia respiratória aguda ,ponto de inflexão superior ,lower inflection poin ,upper inflection point ,static compliance ,complacência estática ,ponto de inflexão inferior ,acute respiratory distress syndrome ,Acute respiratory failur ,Lesão pulmonar aguda ,pressurevolume curves ,curvas pressão-volume - Abstract
OBJECTIVE: Measurement of respiratory compliance based on pressure-volume curves are advocated for assessing the severity of acute respiratory failure. Theaim of the present study was to compare different methods of obtaining pressure volume curves and to evaluate their reproducibility and reliability.MATERIALS AND METHODS: Thoracopulmonary, pulmonary and thoracic pressurevolume curves were obtained in 14 patients and compared using three different methods: supersyringe method, inspiratory occlusions method and constant-flow method, using two different flows: 3 and 9 l.min-1. The slope of the curves, the values of static compliance and upper and lower inflection points, when present, were evaluated.RESULTS: The analysis of the pressure-volume curves through the three different methods showed that the curves obtained using a constant 3 l.min-1 flow weresuperimposable to the ones obtained using the supersyringe and inspiratory occlusions. Curves obtained using the 9 l.min-1 flow method were associated with aslight rightward shift. However, the values of static respiratory compliance and lower inflection points were similar for all patients regardless of the method, allowing the identification of patients with and without lower inflection points.CONCLUSIONS: The evaluation of pressure-volume curves, by any of the tested methods, in patients with acute respiratory failure, allows the evaluation of the values of static respiratory compliance and points of lower inflection, as well as their division into two groups, according to the presence or absence of points, OBJETIVO: As medidas da complacência respiratória, a partir das curvas pressãovolume, são indicadas para avaliar a gravidade da insuficiência respiratória aguda.O objetivo do presente estudo foi comparar diferentes métodos de obtenção das curvas pressão-volume e avaliar sua reprodutibilidade e fidedignidade.MATERIAIS E MÉTODOS: As curvas pressão-volume toracopulmonares, pulmonares e torácicas foram comparadas em 14 pacientes com IRA por três métodos diferentes: a técnica da superseringa, a das oclusões inspiratórias e um novo método automatizado, utilizando fluxos contínuos de 3 e de 9 l.min-1. Foram avaliadas a forma das curvas, bem como os valores de complacência estática e dos pontos de inflexão inferior e superior, quando presentes.RESULTADOS: A análise das curvas pressão-volume pelos diferentes métodos revelou que as curvas obtidas com o método constante de 3 l.min-1 foram superponíveis às obtidas pelos métodos da superseringa e das oclusões inspiratórias, enquanto que com o método de 9 l.min-1 houve um discreto desvio para a direita. Apesar disso, as medidas de complacência estática e os valores dos pontos de inflexão inferior foram semelhantes em todos os métodos, permitindo, todos eles, a identificação de pacientes com e sem pontos de inflexão inferior.CONCLUSÕES: A avaliação das curvas pressão volume em portadores de insuficiência respiratória aguda, por qualquer um dos métodos testados, permite avaliar os valores de complacência estática e de pontos de inflexão inferior, e dividi-los em dois grupos, de acordo com a presença ou ausência de pontos.
- Published
- 2022
28. Avaliação por tomografia computadorizada da hiperdistensão pulmonar induzida por PEEP em indivíduos normais e em pacientes com insuficiência respiratória aguda
- Author
-
R.R. Vieira, Silvia, Puybasset, Louis, Richecoeur, Jack, Lu, Qin, Cluzel, Philippe, Gusman, Pablo, Coriat, Pierre, and Rouby, Jean-Jacques
- Subjects
síndrome da angústia respiratória aguda ,pressão expiratória final positiva ,hiperdistensão ,hyperdistension ,Acute lung injury ,computerized tomography ,recrutamento alveolar ,tomografia computadorizada ,acute respiratory distress syndrome ,Lesão pulmonar aguda ,alveolar recruitment ,positive end-expiratory pressure - Abstract
OBJECTIVE: The aim of the present study was to establish the tomographic limit of lung overdistention in normal individuals as well as to assess positive end-expiratorypressure-induced overdistention and alveolar recruitment in patients with acute lung injury.MATERIALS AND METHODS: Lung distention was first determined in six healthy volunteers in whom computed tomographic sections were obtained at functionalresidual capacity and total lung capacity with a positive airway pressure of 30 cmH2O. Tomographic scans at zero end-expiratory pressure and positive end-expiratorypressure were performed in six patients with acute lung injury. Computed tomographies were performed from the apex to the diaphragm and lung volumes were quantified by the analysis of the density histograms.RESULTS: Analysis of the density histograms in healthy volunteers was monophasic with a peak at -791 ± 12 Housenfield units. In total lung capacity, lung volumeincreased by 79 ± 35% and the peak of lung density decreased to -886 ±26 Housenfield units. More than 70% of the increase in lung volume was located below-900 Housenfield units, suggesting that this value can be considered as the threshold separating normal aeration from overdistention. In patients with acute lung injury, atzero end-expiratory pressure the distribution of density histograms was either monophasic (n=3) or biphasic (n=3), with mean density of -319 ± 34 Housenfieldunits. With positive end-expiratory pressure application, lung volume increased by 47 ± 19%, while lung density decreased to -538 ± Housenfield units. Positive endexpiratory pressure induced a mean alveolar recruitment of 238 ±320 ml.CONCLUSIONS: The limit of overdistention in healthy individuals was -900 Housenfield units. This threshold can be used in patients with acute lung injury fordifferentiating alveolar recruitment from lung overdistention. OBJETIVO: O objetivo do presente estudo foi determinar o limite tomográfico da hiperdistensão pulmonar em indivíduos normais, bem como avaliar o recrutamentoe a hiperdistensão pulmonares induzidos pela pressão expiratória final positiva em pacientes com lesão pulmonar aguda.MATERIAIS E MÉTODOS: Inicialmente, o limite da hiperdistensão pulmonar foi determinado em seis voluntários sadios, nos quais tomografias computadorizadas espiraladas de tórax foram obtidas em capacidade residual funcional e em capacidadepulmonar total mais pressão positiva de 30 cm H2O. Posteriormente, foram avaliados seis pacientes com lesão pulmonar aguda nos quais as tomografias foram obtidas em zero de pressão expiratória final positiva e em pressão expiratória final positiva. As tomografias computadorizadas foram realizadas do ápex ao diafragma, e os volumes pulmonares quantificados por análise dos histogramas de densidade.RESULTADOS: A análise dos histogramas de densidade em voluntários sadios em capacidade residual funcional mostrou histogramas monofásicos, com um pico em-791 + 12 UH. Em capacidade pulmonar total, o volume pulmonar aumentou em 79 + 35% e o pico das densidades pulmonares caiu para -886 + 26 UH. Mais de 70% do aumento no volume pulmonar foi localizado abaixo de -900 UH, sugerindo que este valor possa ser definido como o limite da hiperdistensão. Os pacientes com lesão pulmonar aguda mostraram em zero de pressão expiratória final positiva uma distribuição monofásica (n=3) ou bifásica (n=3), com densidades pulmonares médias situadas em 319 + 34 UH. Com a aplicação de pressão expiratória final positiva, ovolume pulmonar aumentou em 47 + 19%, enquanto que as densidades pulmonares caíram para -538 + 171 UH. Pressão expiratória final positiva induziu um recrutamento alveolar de 320 + 160 ml e uma hiperdistensão de 238 + 320 ml.CONCLUSÕES: O limite de hiperdistensão em voluntários sadios foi de -900 UH. Este limite pode ser usado em pacientes com lesão pulmonar aguda para diferenciarrecrutamento alveolar de hiperdistensão pressão expiratória final positiva induzidos.
- Published
- 2022
29. A lung computed tomography assessment of positive end-expiratory pressureinduced lung overdistention
- Author
-
Vieira, Silvia Regina Rios, Puybasset, Louis, Richecoeur, Jack, Lu, Qin, Cluzel, Philippe, Gusman, Pablo B., Coriat, Pierre, and Rouby, Jean-Jacques
- Subjects
síndrome da angústia respiratória aguda ,Computerized tomography ,Tomografia ,hyperdistension ,Hyperdistension ,Positive end-expiratory pressure ,Pneumopatias ,recrutamento alveolar ,respiratory system ,acute respiratory distress syndrome ,Alveolar recruitment ,Acute respiratory distress syndrome ,Lesão pulmonar aguda ,alveolar recruitment ,respiratory tract diseases ,pressão expiratória final positiva ,hiperdistensão ,Acute lung injury ,computerized tomography ,Insuficiência respiratória ,tomografia computadorizada ,positive end-expiratory pressure - Abstract
OBJECTIVE: The aim of the present study was to establish the tomographic limit of lung overdistention in normal individuals as well as to assess positive end-expiratorypressure-induced overdistention and alveolar recruitment in patients with acute lung injury.MATERIALS AND METHODS: Lung distention was first determined in six healthy volunteers in whom computed tomographic sections were obtained at functionalresidual capacity and total lung capacity with a positive airway pressure of 30 cmH2O. Tomographic scans at zero end-expiratory pressure and positive end-expiratorypressure were performed in six patients with acute lung injury. Computed tomographies were performed from the apex to the diaphragm and lung volumes were quantified by the analysis of the density histograms.RESULTS: Analysis of the density histograms in healthy volunteers was monophasic with a peak at -791 ± 12 Housenfield units. In total lung capacity, lung volumeincreased by 79 ± 35% and the peak of lung density decreased to -886 ±26 Housenfield units. More than 70% of the increase in lung volume was located below-900 Housenfield units, suggesting that this value can be considered as the threshold separating normal aeration from overdistention. In patients with acute lung injury, atzero end-expiratory pressure the distribution of density histograms was either monophasic (n=3) or biphasic (n=3), with mean density of -319 ± 34 Housenfieldunits. With positive end-expiratory pressure application, lung volume increased by 47 ± 19%, while lung density decreased to -538 ± Housenfield units. Positive endexpiratory pressure induced a mean alveolar recruitment of 238 ±320 ml.CONCLUSIONS: The limit of overdistention in healthy individuals was -900 Housenfield units. This threshold can be used in patients with acute lung injury fordifferentiating alveolar recruitment from lung overdistention., OBJETIVO: O objetivo do presente estudo foi determinar o limite tomográfico da hiperdistensão pulmonar em indivíduos normais, bem como avaliar o recrutamentoe a hiperdistensão pulmonares induzidos pela pressão expiratória final positiva em pacientes com lesão pulmonar aguda.MATERIAIS E MÉTODOS: Inicialmente, o limite da hiperdistensão pulmonar foi determinado em seis voluntários sadios, nos quais tomografias computadorizadas espiraladas de tórax foram obtidas em capacidade residual funcional e em capacidadepulmonar total mais pressão positiva de 30 cm H2O. Posteriormente, foram avaliados seis pacientes com lesão pulmonar aguda nos quais as tomografias foram obtidas em zero de pressão expiratória final positiva e em pressão expiratória final positiva. As tomografias computadorizadas foram realizadas do ápex ao diafragma, e os volumes pulmonares quantificados por análise dos histogramas de densidade.RESULTADOS: A análise dos histogramas de densidade em voluntários sadios em capacidade residual funcional mostrou histogramas monofásicos, com um pico em-791 + 12 UH. Em capacidade pulmonar total, o volume pulmonar aumentou em 79 + 35% e o pico das densidades pulmonares caiu para -886 + 26 UH. Mais de 70% do aumento no volume pulmonar foi localizado abaixo de -900 UH, sugerindo que este valor possa ser definido como o limite da hiperdistensão. Os pacientes com lesão pulmonar aguda mostraram em zero de pressão expiratória final positiva uma distribuição monofásica (n=3) ou bifásica (n=3), com densidades pulmonares médias situadas em 319 + 34 UH. Com a aplicação de pressão expiratória final positiva, ovolume pulmonar aumentou em 47 + 19%, enquanto que as densidades pulmonares caíram para -538 + 171 UH. Pressão expiratória final positiva induziu um recrutamento alveolar de 320 + 160 ml e uma hiperdistensão de 238 + 320 ml.CONCLUSÕES: O limite de hiperdistensão em voluntários sadios foi de -900 UH. Este limite pode ser usado em pacientes com lesão pulmonar aguda para diferenciarrecrutamento alveolar de hiperdistensão pressão expiratória final positiva induzidos.
- Published
- 2022
30. Additional file 4 of Usefulness of lung ultrasound for early detection of hospital-acquired pneumonia in cardiac critically ill patients on venoarterial extracorporeal membrane oxygenation
- Author
-
Pasqueron, Jean, Dureau, Pauline, Arcile, Gauthier, Duceau, Baptiste, Hariri, Geoffroy, Lepère, Victoria, Lebreton, Guillaume, Rouby, Jean-Jacques, and Bouglé, Adrien
- Abstract
Additional file 4: Table S1. Bundle of care to prevent pneumonia in VA ECMO patients. Table S2. Lung ultrasound realization: each of the following ultrasound signs was looked for according to this standardized sequence. Table S3. sCPIS score as described by Luna et al [17]. Table S4. LUS-sCPIS score as described by Dureau et al [10]. The criterion based on the interpretation of the chest radiograph is the original sCPIS score is replaced by the presence or absence of a shunt on color Doppler. Table S5. comparison of the two groups, with and without pneumonia, according to the individualized criteria of the sCPIS score. Categorical variables are expressed as headcount (%).
- Published
- 2022
- Full Text
- View/download PDF
31. Inhaled Nitric Oxide in Acute Respiratory Failure
- Author
-
Rouby, Jean-Jacques, Catravas, John D., editor, Callow, Allan D., editor, and Ryan, Una S., editor
- Published
- 1996
- Full Text
- View/download PDF
32. Effects of dexmedetomidine on hemodynamic, oxygenation, microcirculation, and inflammatory markers in a porcine model of sepsis
- Author
-
Carnicelli, Paulo, primary, Otsuki, Denise Aya, additional, Monteiro Filho, Adalberto, additional, Kahvegian, Marcia Aparecida Portela, additional, Ida, Keila Kazue, additional, Auler-Jr, José Otavio Costa, additional, Rouby, Jean-Jacques, additional, and Fantoni, Denise Tabacchi, additional
- Published
- 2022
- Full Text
- View/download PDF
33. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
- Author
-
Zhu, Yinggang, Monsel, Antoine, Roberts, Jason A, Pontikis, Konstantinos, Mimoz, Olivier, Rello, Jordi, Qu, Jieming, Rouby, Jean-Jacques, European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP), Laterre, Pierre-François, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Fudan University [Shanghai], Service d'Anesthésie réanimation [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière] (I3), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre d’Investigation Clinique intégré en Biothérapies et immunologie [AP-HP pitié-salpêtrière, Paris] (CIC-BTi), Departement Hospitalo- Universitaire - Inflammation, Immunopathologie, Biothérapie [Paris] (DHU - I2B), Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], University of Queensland [Brisbane], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), National and Kapodistrian University of Athens (NKUA), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III [Madrid] (ISC), Vall d’Hebron Research Institute (VHIR), Shanghai Jiao Tong University [Shanghai], Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Institut Català de la Salut, [Zhu Y] Department of Pulmonary and Critical Care Medicine, Hua-Dong Hospital, Fudan University, Shanghai 200433, China. [Monsel A] Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Medicine Sorbonne University, 75012 Paris, France. Unité Mixte de Recherche (UMR)-S 959, Immunology-Immunopathology-Immunotherapy (I3), Institut National de la Santé et de la Recherche Médicale (INSERM), 75012 Paris, France. Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75012 Paris, France. [Roberts JA] Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75012 Paris, France. University of Queensland Centre for Clinical Research, Faculty of Medicine The University of Queensland, 4006 Brisbane, Australia. Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women’s Hospital, 4006 Brisbane, Australia. Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, 30029 Nîmes, France. [Pontikis K] Intensive Care Unit, First Department of Respiratory Medicine, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece. [Mimoz O] Anaesthesiology and Intensive Care Department, University Hospital of Poitiers, University of Poitiers, 86000 Poitiers, France. [Rello J] Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain. Recerca Clínica/Innovació en la Pneumònia i Sèpsia (CRIPS), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, 30029 Nîmes, France, Vall d'Hebron Barcelona Hospital Campus, CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
- Subjects
0301 basic medicine ,[SDV]Life Sciences [q-bio] ,Antibiotics ,Review ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,Gastroenterology ,0302 clinical medicine ,Tracheobronchitis ,Medicine and Health Sciences ,Medicaments antibacterians - Ús terapèutic ,Medicine ,NOSOCOMIAL PNEUMONIA ,030212 general & internal medicine ,colistin ,multidrug resistant gram-negative bacteria ,Biology (General) ,nebulized polymyxin ,Pneumònia - Tractament ,Ventilator-associated pneumonia ,ventilator-associated tracheobronchitis ,3. Good health ,medicine.anatomical_structure ,RESISTANT ACINETOBACTER-BAUMANNII ,Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [CHEMICALS AND DRUGS] ,Other subheadings::Other subheadings::/administration & dosage [Other subheadings] ,CRITICALLY-ILL PATIENTS ,Malalties bacterianes gramnegatives - Tractament ,medicine.drug ,Microbiology (medical) ,INHALED COLISTIMETHATE SODIUM ,medicine.medical_specialty ,infecciones bacterianas y micosis::infección::infección hospitalaria::neumonía asociada al ventilador [ENFERMEDADES] ,AEROSOLIZED COLISTIN ,QH301-705.5 ,POLYMYXIN-B HEMOPERFUSION ,medicine.drug_class ,030106 microbiology ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,phramacokinetic ,acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos [COMPUESTOS QUÍMICOS Y DROGAS] ,Microbiology ,03 medical and health sciences ,ventilator-associated pneumonia ,Pharmacokinetics ,Virology ,Internal medicine ,pharmacodynamics ,SYSTEMIC PHARMACOKINETICS ,Bacterial Infections and Mycoses::Infection::Cross Infection::Pneumonia, Ventilator-Associated [DISEASES] ,Otros calificadores::Otros calificadores::/administración & dosificación [Otros calificadores] ,PLUS INTRAVENOUS COLISTIN ,Lung ,nebulized colistimethate sodium ,business.industry ,Septic shock ,SEPTIC SHOCK ,PSEUDOMONAS-AERUGINOSA ,polylyxin resistance ,medicine.disease ,Pneumonia ,technique of nebulization ,Colistin ,business - Abstract
Colistin; Phramacokinetic; Technique of nebulization Colistina; Farmacocinètica; Tècnica de nebulització Colistina; Farmacocinético; Técnica de nebulización Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are hydrophilic. These physico-chemical characteristics impair crossing of the alveolo-capillary membrane but enable the disruption of the bacterial wall of GNB and the aggregation of the circulating lipopolysaccharide. Intravenous CMS is rapidly cleared by glomerular filtration and tubular excretion, and 20–25% is spontaneously hydrolyzed to colistin. Urine colistin is substantially reabsorbed by tubular cells and eliminated by biliary excretion. Colistin is a concentration-dependent antibiotic with post-antibiotic and inoculum effects. As CMS conversion to colistin is slower than its renal clearance, intravenous administration can lead to low plasma and lung colistin concentrations that risk treatment failure. Following nebulization of high doses, colistin (200,000 international units/24h) lung tissue concentrations are > five times minimum inhibitory concentration (MIC) of GNB in regions with multiple foci of bronchopneumonia and in the range of MIC breakpoints in regions with confluent pneumonia. Future research should include: (1) experimental studies using lung microdialysis to assess the PK/PD in the interstitial fluid of the lung following nebulization of high doses of colistin; (2) superiority multicenter randomized controlled trials comparing nebulized and intravenous CMS in patients with pandrug-resistant GNB ventilator-associated pneumonia and ventilator-associated tracheobronchitis; (3) non-inferiority multicenter randomized controlled trials comparing nebulized CMS to intravenous new cephalosporines/ß-lactamase inhibitors in patients with extensive drug-resistant GNB ventilator-associated pneumonia and ventilator-associated tracheobronchitis. This research received no external funding.
- Published
- 2021
34. Experimental ventilator-associated pneumonia: distribution of lung infection and consequences for lung aeration
- Author
-
Vieira Silvia Regina Rios, Goldstein Ivan, Lenaour Gilles, Marquette Charles-Hugo, and Rouby Jean-Jacques
- Subjects
Ventilator associated pneumonia ,Infectious and parasitic diseases ,RC109-216 ,Microbiology ,QR1-502 - Abstract
Ventilator-associated pneumonia (VAP) has been described in humans and in experimental animals. The most severe lesions are located in dependent lung segments along a sterno-vertebral axis, however the cephalocaudal distribution of lung infection remains unknown. We used an experimental model to evaluate the distribution of lung infection, considering its anteroposterior and cephalocaudal gradient, and its impact on lung aeration. Ten healthy domestic piglets were anesthetized, paralyzed and mechanically ventilated for 59 hours in the prone position. At the end of the experiment they were sacrificed and their lungs were fixed. Six segments were analyzed: a non-dependant (ND) and a dependant (D) segment of the upper (UL), middle (ML) and lower (LL) lobes. The presence of healthy lung or of histological infectious lesions was analyzed with a semi-quantitative method. The regional distribution of lung infection was compared between upper, middle and lower lobes, as well as between dependant and non-dependant regions. The presence of infectious lesions was correlated with measurements of lung aeration. Nine of the ten piglets developed VAP. Infectious lesions were distributed along a sterno-vertebral and a cephalocaudal gradient; the lower and middle lobes were more frequently infected than the upper lobes. There was an inverse correlation (R= - 0.902) between the development of lung lesions and lung aeration. In conclusion, VAP was a frequent complication in healthy mechanically ventilated piglets, showing an anteroposterior as well as a cephalocaudal gradient. As expected, development of lung infection was accompanied by a corresponding loss of aeration.
- Published
- 2003
35. First experience of liver transplantation with type 2 donation after cardiac death in France
- Author
-
Savier, Eric, Dondero, Federica, Vibert, Eric, Eyraud, Daniel, Brisson, Hélène, Riou, Bruno, Fieux, Fabienne, Naili-Kortaia, Salima, Castaing, Denis, Rouby, Jean-Jacques, Langeron, Olivier, Dokmak, Safi, Hannoun, Laurent, and Vaillant, Jean-Christophe
- Published
- 2015
- Full Text
- View/download PDF
36. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial
- Author
-
Le Guen, Morgan, Liu, Ngai, Bourgeois, Eric, Chazot, Thierry, Sessler, Daniel I., Rouby, Jean-Jacques, and Fischler, Marc
- Published
- 2013
- Full Text
- View/download PDF
37. Usefulness of Lung Ultrasound for early detection of Hospital-Acquired Pneumonia in Patients on Veno-Arterial Extra Corporeal Membrane Oxygenation.
- Author
-
Pasqueron, Jean, primary, Dureau, Pauline, additional, Arcile, Gauthier, additional, Duceau, Baptiste, additional, Hariri, Geoffroy, additional, Lepere, Victoria, additional, Lebreton, Guillaume, additional, Rouby, Jean-Jacques, additional, and Bouglé, Adrien, additional
- Published
- 2021
- Full Text
- View/download PDF
38. Additional file 1 of Management of severe trauma worldwide: implementation of trauma systems in emerging countries: China, Russia and South Africa
- Author
-
Zhou, Jing, Wang, Tianbing, Belenkiy, Igor, Hardcastle, Timothy Craig, Rouby, Jean-Jacques, and Jiang, Baoguo
- Abstract
Additional file 1. The Chinese trauma system: historical background.
- Published
- 2021
- Full Text
- View/download PDF
39. Additional file 2 of Management of severe trauma worldwide: implementation of trauma systems in emerging countries: China, Russia and South Africa
- Author
-
Zhou, Jing, Wang, Tianbing, Belenkiy, Igor, Hardcastle, Timothy Craig, Rouby, Jean-Jacques, and Jiang, Baoguo
- Abstract
Additional file 2. The Russian trauma system: historical background.
- Published
- 2021
- Full Text
- View/download PDF
40. Additional file 3 of Management of severe trauma worldwide: implementation of trauma systems in emerging countries: China, Russia and South Africa
- Author
-
Zhou, Jing, Wang, Tianbing, Belenkiy, Igor, Hardcastle, Timothy Craig, Rouby, Jean-Jacques, and Jiang, Baoguo
- Abstract
Additional file 3. The South African trauma system: historical background.
- Published
- 2021
- Full Text
- View/download PDF
41. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials
- Author
-
Monsel, Antoine, Torres, Antoni, Zhu, Yinggang, Pugin, Jerome, Rello, Jordi, Rouby, Jean-Jacques, European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP), Laterre, Pierre-François, Service d'Anesthésie réanimation [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Fudan University [Shanghai], Geneva University Hospitals and Geneva University, Vall d’Hebron Research Institute (VHIR), Instituto de Salud Carlos III [Madrid] (ISC), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, and UCL - (SLuc) Service de soins intensifs
- Subjects
0301 basic medicine ,Microbiology (medical) ,Nebulized antibiotics ,Sedation ,[SDV]Life Sciences [q-bio] ,030106 microbiology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Administration, Inhalation ,Gram-Negative Bacteria ,medicine ,Humans ,030212 general & internal medicine ,Randomized Controlled Trials as Topic ,Lung ,Inhalation ,business.industry ,Nebulizers and Vaporizers ,Ventilator-associated pneumonia ,Pneumonia, Ventilator-Associated ,medicine.disease ,3. Good health ,Anti-Bacterial Agents ,Pneumonia ,Infectious Diseases ,medicine.anatomical_structure ,Amikacin ,Anesthesia ,medicine.symptom ,business ,medicine.drug - Abstract
International audience; Purpose of review: Although experimental evidence supports the use of nebulized antibiotics in ventilator-associated pneumonia (VAP), two recent multicenter randomized controlled trials (RCTs) have failed to demonstrate any benefit in VAP caused by Gram-negative bacteria (GNB). This review examines the methodological requirements concerning future RCTs.Recent findings: High doses of nebulized antibiotics are required to reach the infected lung parenchyma. Breath-synchronized nebulizers do not allow delivery of high doses. Mesh nebulizers perform better than jet nebulizers. Epithelial lining fluid concentrations do not reflect interstitial lung concentrations in patients receiving nebulized antibiotics. Specific ventilator settings for optimizing lung deposition require sedation to avoid patient's asynchrony with the ventilator.Summary: Future RCTs should compare a 3-5 day nebulization of amikacin or colistimethate sodium (CMS) to a 7-day intravenous administration of a new cephalosporine/ß-lactamase inhibitor. Inclusion criteria should be a VAP or ventilator-associated tracheobronchitis caused by documented extensive-drug or pandrug resistant GNB. If the GNB remains susceptible to aminoglycosides, nebulized amikacin should be administered at a dose of 40 mg/kg/day. If resistant to aminoglycosides, nebulized CMS should be administered at a dose of 15 millions international units (IU)/day. In VAP caused by pandrug-resistant GNB, 15 millions IU/day nebulized CMS (substitution therapy) should be compared with a 9 millions IU/day intravenous CMS.
- Published
- 2021
42. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.
- Author
-
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Zhu, Yinggang, Monsel, Antoine, Roberts, Jason A, Pontikis, Konstantinos, Mimoz, Olivier, Rello, Jordi, Qu, Jieming, Rouby, Jean-Jacques, European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP), Laterre, Pierre-François, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Zhu, Yinggang, Monsel, Antoine, Roberts, Jason A, Pontikis, Konstantinos, Mimoz, Olivier, Rello, Jordi, Qu, Jieming, Rouby, Jean-Jacques, European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP), and Laterre, Pierre-François
- Abstract
Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are hydrophilic. These physico-chemical characteristics impair crossing of the alveolo-capillary membrane but enable the disruption of the bacterial wall of GNB and the aggregation of the circulating lipopolysaccharide. Intravenous CMS is rapidly cleared by glomerular filtration and tubular excretion, and 20-25% is spontaneously hydrolyzed to colistin. Urine colistin is substantially reabsorbed by tubular cells and eliminated by biliary excretion. Colistin is a concentration-dependent antibiotic with post-antibiotic and inoculum effects. As CMS conversion to colistin is slower than its renal clearance, intravenous administration can lead to low plasma and lung colistin concentrations that risk treatment failure. Following nebulization of high doses, colistin (200,000 international units/24h) lung tissue concentrations are > five times minimum inhibitory concentration (MIC) of GNB in regions with multiple foci of bronchopneumonia and in the range of MIC breakpoints in regions with confluent pneumonia. Future research should include: (1) experimental studies using lung microdialysis to assess the PK/PD in the interstitial fluid of the lung following nebulization of high doses of colistin; (2) superiority multicenter randomized controlled trials comparing nebulized and intravenous CMS in patients with pandrug-resistant GNB ventilator-associated pneumonia and ventilator-associated tracheobronchitis; (3) non-inferiority multicenter randomized controlled trials comparing nebulized CMS to intravenous new cephalosporines/ß-lactamase inhibitors in patients with extensive drug-resistant GNB ventilator-associated pneumonia and ventilator-associated tracheobronchitis.
- Published
- 2021
43. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials.
- Author
-
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Monsel, Antoine, Torres, Antoni, Zhu, Yinggang, Pugin, Jerome, Rello, Jordi, Rouby, Jean-Jacques, European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP), Laterre, Pierre-François, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Monsel, Antoine, Torres, Antoni, Zhu, Yinggang, Pugin, Jerome, Rello, Jordi, Rouby, Jean-Jacques, European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP), and Laterre, Pierre-François
- Abstract
PURPOSE OF REVIEW: Although experimental evidence supports the use of nebulized antibiotics in ventilator-associated pneumonia (VAP), two recent multicenter randomized controlled trials (RCTs) have failed to demonstrate any benefit in VAP caused by Gram-negative bacteria (GNB). This review examines the methodological requirements concerning future RCTs. RECENT FINDINGS: High doses of nebulized antibiotics are required to reach the infected lung parenchyma. Breath-synchronized nebulizers do not allow delivery of high doses. Mesh nebulizers perform better than jet nebulizers. Epithelial lining fluid concentrations do not reflect interstitial lung concentrations in patients receiving nebulized antibiotics. Specific ventilator settings for optimizing lung deposition require sedation to avoid patient's asynchrony with the ventilator. SUMMARY: Future RCTs should compare a 3-5 day nebulization of amikacin or colistimethate sodium (CMS) to a 7-day intravenous administration of a new cephalosporine/ß-lactamase inhibitor. Inclusion criteria should be a VAP or ventilator-associated tracheobronchitis caused by documented extensive-drug or pandrug resistant GNB. If the GNB remains susceptible to aminoglycosides, nebulized amikacin should be administered at a dose of 40 mg/kg/day. If resistant to aminoglycosides, nebulized CMS should be administered at a dose of 15 millions international units (IU)/day. In VAP caused by pandrug-resistant GNB, 15 millions IU/day nebulized CMS (substitution therapy) should be compared with a 9 millions IU/day intravenous CMS.
- Published
- 2021
44. International evidence-based recommendations for point-of-care lung ultrasound
- Author
-
Volpicelli, Giovanni, Elbarbary, Mahmoud, Blaivas, Michael, Lichtenstein, Daniel A., Mathis, Gebhard, Kirkpatrick, Andrew W., Melniker, Lawrence, Gargani, Luna, Noble, Vicki E., Via, Gabriele, Dean, Anthony, Tsung, James W., Soldati, Gino, Copetti, Roberto, Bouhemad, Belaid, Reissig, Angelika, Agricola, Eustachio, Rouby, Jean-Jacques, Arbelot, Charlotte, Liteplo, Andrew, Sargsyan, Ashot, Silva, Fernando, Hoppmann, Richard, Breitkreutz, Raoul, Seibel, Armin, Neri, Luca, Storti, Enrico, Petrovic, Tomislav, and International Liaison Committee on Lung Ultrasound (ILC-LUS) for the International Consensus Conference on Lung Ultrasound (ICC-LUS)
- Published
- 2012
- Full Text
- View/download PDF
45. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa
- Author
-
Lu, Qin, Girardi, Cassio, Zhang, Mao, Bouhemad, Belaïd, Louchahi, Kamel, Petitjean, Olivier, Wallet, Frédéric, Becquemin, Marie-Helene, Le Naour, Gilles, Marquette, Charles-Hugo, and Rouby, Jean-Jacques
- Published
- 2010
- Full Text
- View/download PDF
46. Multiplane ultrasound approach to quantify pleural effusion at the bedside
- Author
-
Remérand, Francis, Dellamonica, Jean, Mao, Zhang, Ferrari, Fabio, Bouhemad, Belaïd, Jianxin, Yang, Arbelot, Charlotte, Lu, Qin, Ichaï, Carole, and Rouby, Jean-Jacques
- Published
- 2010
- Full Text
- View/download PDF
47. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa
- Author
-
Ferrari, Fabio, Lu, Qin, Girardi, Cassio, Petitjean, Olivier, Marquette, Charles-Hugo, Wallet, Frederic, and Rouby, Jean-Jacques
- Subjects
Ceftazidime -- Dosage and administration ,Ceftazidime -- Research ,Bacterial pneumonia -- Drug therapy ,Bacterial pneumonia -- Patient outcomes ,Bacterial pneumonia -- Research ,Pneumonia -- Drug therapy ,Pneumonia -- Patient outcomes ,Pneumonia -- Research ,Pseudomonas aeruginosa -- Causes of ,Pseudomonas aeruginosa -- Care and treatment ,Pseudomonas aeruginosa -- Research ,Artificial respiration -- Complications and side effects ,Artificial respiration -- Research ,Health care industry - Abstract
Byline: Fabio Ferrari (1,2), Qin Lu (1,2), Cassio Girardi (3), Olivier Petitjean (4), Charles-Hugo Marquette (5), Frederic Wallet (6), Jean-Jacques Rouby (1,2) Keywords: Nebulization; Ceftazidime; Pneumonia; Pseudomonas aeruginosa; Mechanical ventilation; Treatment Abstract: Purpose Ventilator-associated pneumonia caused by Pseudomonas aeruginosa with impaired sensitivity to ceftazidime is frequent in critically ill patients. The aim of the study was to compare lung tissue deposition and antibacterial efficiency between nebulized and intravenous administrations of ceftazidime in ventilated piglets with pneumonia caused by Pseudomonas aeruginosa with impaired sensitivity to ceftazidime. Methods Ceftazidime was administered 24 h following the intra-bronchial inoculation of Pseudomonas aeruginosa (minimum inhibitory concentration = 16 ug ml.sup.-1), either by nebulization (25 mg kg.sup.-1 every 3 h, n = 6) or by continuous intravenous infusion (90 mg kg.sup.-1 over 24 h after an initial rapid infusion of 30 mg kg.sup.-1, n = 6). Four non-treated inoculated animals served as controls. All piglets were killed 48 h (intravenous and control groups) or 51 h (aerosol group) after inoculation. Lung tissue concentrations and lung bacterial burden were assessed on multiple post-mortem sub-pleural lung specimens [(lower limit of quantitation = 10.sup.2 colony forming unit (cfu g.sup.-1)]. Results Ceftazidime trough lung tissue concentrations following nebulization were greater than steady-state lung tissue concentrations following continuous intravenous infusion [median and interquartile range, 24.8 (12.6--59.6) ug g.sup.-1 vs. 6.1 (4.6--10.8) ug g.sup.-1] (p < 0.001). After 24 h of ceftazidime administration, 83% of pulmonary segments had bacterial counts Conclusion Nebulized ceftazidime provides more efficient bacterial killing in ventilated piglets with pneumonia caused by Pseudomonas aeruginosa with impaired sensitivity to ceftazidime. Author Affiliation: (1) Reanimation Polyvalente Pierre Viars, Departement d'Anesthesie-Reanimation, UPMC Univ Paris 06, Hopital Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris, 47-83 boulevard de l'Hopital, 75013, Paris, France (2) Polyvalent Intensive Care Unit Pierre Viars, La Pitie-Salpetriere Hospital, University Pierre et Marie Curie, Paris, France (3) Department of Anesthesiology, Federal University of Sao Paulo, Escola Paulista de Medicina, Sao Paulo, Brazil (4) Department of Pharmacology, Avicenne Hospital, Bobigny, France (5) DHURE and INSERM U 416, University of Medicine, Lille, France (6) Department of Bacteriology, University of Medicine, Lille, France Article History: Registration Date: 17/07/2009 Received Date: 03/03/2009 Accepted Date: 08/07/2009 Online Date: 04/08/2009
- Published
- 2009
48. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers
- Author
-
Ferrari, Fabio, Liu, Zhi-Hai, Lu, Qin, Becquemin, Marie-Helene, Louchahi, Kamel, Aymard, Guy, Marquette, Charles-Hugo, and Rouby, Jean-Jacques
- Subjects
Ceftazidime -- Dosage and administration ,Ceftazidime -- Physiological aspects ,Aerosol therapy -- Methods ,Aerosol therapy -- Patient outcomes ,Aerosol therapy -- Physiological aspects ,Aerosol therapy -- Research ,Pharmacokinetics -- Research ,Health care industry - Abstract
Byline: Fabio Ferrari (1), Zhi-Hai Liu (2), Qin Lu (3,8), Marie-Helene Becquemin (4), Kamel Louchahi (5), Guy Aymard (6), Charles-Hugo Marquette (7), Jean-Jacques Rouby (3) Keywords: Ultrasonic; Vibrating plate; Nebulizer; Nebulization of antibiotics; Lung tissue concentration Abstract: Objective To compare the efficiency of an Aeroneb Pro vibrating plate and an Atomisor MegaHertz ultrasonic nebulizer for providing ceftazidime distal lung deposition. Design In vitro experiments. One gram of cetazidime was nebulized in respiratory circuits and mass median aerodynamic diameter of particles generated by ultrasonic and vibrating plate nebulizers was compared using a laser velocimeter. In vivo experiments. Lung tissue concentrations and extrapulmonary depositions were measured in ten anesthetized ventilated piglets with healthy lungs that received 1 g of ceftazidime by nebulization with either an ultrasonic (n = 5), or a vibrating plate (n = 5) nebulizer. Setting A two-bed Experimental Intensive Care Unit of a University School of Medicine. Intervention Following sacrifice, 5 subpleural specimens were sampled in dependent and nondependent lung regions for measuring ceftazidime lung tissue concentrations by high-performance liquid chromatography. Measurements and results Mass median aerodynamic diameters generated by both nebulizers were similar with more than 95% of the particles between 0.5 and 5 um. Lung tissue concentrations were 553 +- 123 [95% confidence interval: 514--638] ug g.sup.-1 using ultrasonic nebulizer, and 452 +- 172 [95% confidence interval: 376--528] ug g.sup.-1 using vibrating plate nebulizers (NS). Extrapulmonary depositions were, respectively, of 38 +- 5% (ultrasonic) and 34 +- 4% (vibrating plate) (NS). Conclusions Vibrating plate nebulizer is comparable to ultrasonic nebulizers for ceftazidime nebulization. It may represent a new attractive technology for inhaled antibiotic therapy. Author Affiliation: (1) Department of Anesthesiology, Faculdade de Medicina da Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu, Brazil (2) Department of Emergency Medicine, School of Medicine, Second Affiliated Hospital, Zhejiang University, Hangzhou, China (3) Surgical Intensive Care Unit Pierre Viars, Department of Anesthesiology and Critical Care Medicine, Assistance Publique--Hopitaux de Paris, La Pitie-Salpetriere Hospital, University of Paris-6, Paris, France (4) Department of Respiratory Physiology, Assistance Publique--Hopitaux de Paris, La Pitie-Salpetriere Hospital, Denis Diderot University, UPRES 2397, Paris, France (5) Department of Pharmacology, Assistance Publique-Hopitaux de Paris, Avicenne Hospital, Bobigny, France (6) Department of Pharmacology, Assistance Publique--Hopitaux de Paris, La Pitie-Salpetriere Hospital, Paris, France (7) Departement Hospitalo-Universitaire de Recherche Experimentale and INSERM U 416 of Institut Pasteur, Universirty of Lille, Lille, France (8) Reanimation Chirurgicale Polyvalente Pierre Viars, Department of Anesthesiology and Critical Care, La Pitie-Salpetriere Hospital, 47-83 boulevard de l'Hopital, 75013, Paris, France Article History: Registration Date: 11/04/2008 Received Date: 05/07/2007 Accepted Date: 06/04/2008 Online Date: 30/04/2008 Article note: Vibrating plate nebulizers were provided by Aerogen Nektar Corporation, Galway, Ireland. Other support was provided from institutional and/or departmental source. None of the authors received any financial support from the manufacturers of ultrasonic and vibrating plate nebulizers.
- Published
- 2008
49. The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation.
- Author
-
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Rouby, Jean-Jacques, Monsel, Antoine, Leone, Marc, Mimoz, Olivier, Laterre, Pierre-François, Pugin, Jérôme, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Rouby, Jean-Jacques, Monsel, Antoine, Leone, Marc, Mimoz, Olivier, Laterre, Pierre-François, and Pugin, Jérôme
- Abstract
Animal studies demonstrate that nebulised aminoglycosides and colimycin (polymyxin E) deliver higher antibiotic concentrations and greater bactericidal activity in the lung parenchyma infected by both sensitive and multidrug-resistant (MDR) Gramnegative bacteria (GNB) [1]. However, superiority of nebulised over intravenous (IV) aminoglycosides and colimycin in patients with ventilator-associated pneumonia (VAP) remains to be demonstrated. Clinical studies are sparse, heterogeneous in terms of aims and methods, and have enrolled a limited number of patients. As a consequence, recommendations from American and European academic societies for using nebulised antibiotics are limited, based on a weak level-of-evidence and sometimes divergent.[...]
- Published
- 2020
50. The INHALE trial: multiple reasons for a negative result.
- Author
-
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Rouby, Jean-Jacques, Monsel, Antoine, Ehrmann, Stephan, Bouglé, Adrien, Laterre, Pierre-François, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, Rouby, Jean-Jacques, Monsel, Antoine, Ehrmann, Stephan, Bouglé, Adrien, and Laterre, Pierre-François
- Abstract
The INHALE trial, a Bayer-sponsored phase 3 trial in critically ill patients with pneumonia caused by Gram-negative bacteria by Michael Niederman and colleagues,1 did not find aerosolised amikacin as an adjunctive therapy to intravenous antibiotics to be superior to intravenous antibiotics alone. The study design, the doses of amikacin, and the technique of nebulisation are all likely to explain this negative result. [...]
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.